Neurological Disorder Treatment Devices and Methods

Publication ID: 24-11857380_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Neurological Disorder Treatment Devices and Methods,” Published Technical Disclosure No. 24-11857380_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857380_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,380.

Summary of the Inventive Concept

The present inventive concept extends the core technology of cardiac arrhythmia treatment devices to novel applications in treating neurological disorders, including sleep disorders, chronic pain, cognitive function enhancement, gastrointestinal disorders, and anxiety disorders.

Background and Problem Solved

The original patent focuses on cardiac arrhythmia treatment devices and delivery methods. However, the limitations of these devices are confined to cardiac applications. The present inventive concept addresses the need for novel therapeutic approaches to treat various neurological disorders, leveraging the core technology of pulse generators and leads to stimulate specific regions of the brain, spine, and nervous system.

Detailed Description of the Inventive Concept

The inventive concept comprises a system and method for treating neurological disorders, utilizing a pulse generator configured to generate therapeutic electrical pulses for stimulating specific regions of the brain, spine, or nervous system. The system includes a lead having a distal end configured to transmit the therapeutic electrical pulses to the targeted area. The pulse generator is capable of generating pulses synchronized with the patient's brain waves, and the lead is designed for implantation adjacent to the targeted region. The inventive concept encompasses various embodiments, including devices for treating sleep disorders, chronic pain, cognitive function enhancement, gastrointestinal disorders, and anxiety disorders.

Novelty and Inventive Step

The present inventive concept introduces a novel application of cardiac arrhythmia treatment technology to neurological disorders, providing a non-obvious solution to the problem of treating these disorders. The inventive concept's novelty lies in its extension of the core technology to new fields, including sleep disorders, chronic pain, cognitive function enhancement, gastrointestinal disorders, and anxiety disorders.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include variations in pulse generator design, lead configuration, and implantation methods. For example, the pulse generator could be miniaturized for implantation within a specific region of the brain or spine, or the lead could be designed with multiple electrodes for stimulating different areas of the nervous system.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the neurological disorder treatment market, with potential applications in treating sleep disorders, chronic pain, cognitive function enhancement, gastrointestinal disorders, and anxiety disorders. The target industries include pharmaceutical companies, medical device manufacturers, and healthcare providers focused on neurological disorder treatment.

CPC Classifications

SectionClassGroup
A A61 A61B90/39
A A61 A61B90/02
A A61 A61N1/0504
A A61 A61N1/0563
A A61 A61N1/0587
A A61 A61N1/362
A A61 A61N1/3621
A A61 A61N1/36521
A A61 A61N1/36542
A A61 A61N1/36557
A A61 A61N1/3787
A A61 A61N1/37217
A A61 A61N1/37264
A A61 A61N1/3956
A A61 A61B2090/3966
A A61 A61B2090/3983
A A61 A61N1/059
A A61 A61N1/3752

Field of Art

Biomedical electrical stimulation devices, specifically implantable pulse generators and neural/cardiac stimulation systems, encompassing medical device design, electrical pulse generation, and targeted neurological/cardiac interventions

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degree, expertise in electrical stimulation technologies, understanding of neural/cardiac physiology, and knowledge of implantable medical device design principles

Obviousness Rationale

A PHOSITA would recognize the fundamental similarity between cardiac arrhythmia treatment and neurological disorder treatment technologies, understanding that electrical pulse generation and targeted lead placement are transferable principles across physiological systems. The core technological framework of pulse generation, lead design, and therapeutic electrical stimulation remains consistent across different bodily systems. The variations disclosed represent predictable extensions of existing medical device technology using known engineering techniques.

Obvious Combinations & Variations

Source Patent Element
Cardiac lead insertion method using intercostal space placement
PTD Variation
Lead placement adjacent to neurological targets like spine or brain
Obviousness Reasoning
Predictable adaptation of established lead insertion techniques to alternative anatomical targets with known surgical approaches
Source Patent Element
Pulse generator configured to generate therapeutic electrical pulses
PTD Variation
Pulse generator synchronized with brain waves for cognitive enhancement
Obviousness Reasoning
Known technique of pulse synchronization applied to a new physiological context with expected therapeutic outcomes
Source Patent Element
Electrical pulse generation for cardiac rhythm control
PTD Variation
Electrical pulse generation for stimulating enteric nervous system
Obviousness Reasoning
Transferable electrical stimulation methodology across different physiological systems using established medical device design principles
Source Patent Element
Implantable pulse generator with lead for electrical signal transmission
PTD Variation
Pulse generator for vagus nerve stimulation to treat anxiety disorders
Obviousness Reasoning
Routine engineering adaptation of existing pulse generation technology to alternative neurological intervention targets
Source Patent Element
Therapeutic electrical pulse transmission through implantable lead
PTD Variation
Multiple electrode lead design for stimulating different nervous system regions
Obviousness Reasoning
Predictable design variation using known multi-electrode lead configuration techniques
35 U.S.C. § 103 Summary: Based on US Patent 11857380's comprehensive disclosure of electrical pulse generation and lead placement methodologies, the present publication demonstrates that the extension of cardiac stimulation technologies to neurological disorder treatment would be obvious to a person having ordinary skill in the art. The technological principles underlying pulse generation, lead design, and targeted electrical stimulation are fundamentally transferable across physiological systems, rendering the disclosed variations predictable and non-inventive under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,380
TitleCardiac arrhythmia treatment devices and delivery
Assignee(s)AtaCor Medical, Inc.